Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.